Evidence map›Paper›PMID 26309357›Full record

ArticleWorld journal of gastroenterology2015

Reciprocal impact of host factors and Helicobacter pylori genotypes on gastric diseases.

Sahar Honarmand-Jahromy, Farideh Siavoshi, Reza Malekzadeh, Taher Nejad Sattari, Saeid Latifi-Navid

Open access · hybridAbstract read
In one paragraph

Article in World journal of gastroenterology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 11 citations in OpenAlex.

  1. Pathogens (Basel, Switzerland) · 2024
    Review
  2. Detection ofThe Journal of international medical research · 2024
    Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Sahar Honarmand-JahromySahar Honarmand-Jahromy, Taher Nejad Sattari, Department of Biology, Tehran Science and Research Branch, Islamic Azad University, Tehran 1477893855, Iran.
Farideh SiavoshiSahar Honarmand-Jahromy, Taher Nejad Sattari, Department of Biology, Tehran Science and Research Branch, Islamic Azad University, Tehran 1477893855, Iran.
Reza MalekzadehSahar Honarmand-Jahromy, Taher Nejad Sattari, Department of Biology, Tehran Science and Research Branch, Islamic Azad University, Tehran 1477893855, Iran.
Taher Nejad SattariSahar Honarmand-Jahromy, Taher Nejad Sattari, Department of Biology, Tehran Science and Research Branch, Islamic Azad University, Tehran 1477893855, Iran.
Saeid Latifi-NavidSahar Honarmand-Jahromy, Taher Nejad Sattari, Department of Biology, Tehran Science and Research Branch, Islamic Azad University, Tehran 1477893855, Iran.
Islamic Azad University, Science and Research Branch · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo assess the impact of Helicobacter pylori (H. pylori) genotypes and patient age and sex on the development of gastric diseases.

methodsH. pylori-infected patients (n = 233) referred to the endoscopy unit at Tehran University of Medical Sciences (Tehran, Iran) were diagnosed with chronic gastritis (CG), gastric ulcer (GU), or duodenal ulcer (DU). Brucella blood agar was used for biopsy cultures and H. pylori isolation under microaerobic conditions. H. pylori isolates were confirmed with biochemical tests and through amplification of the 16S rRNA gene. DNA was extracted from fresh cultures of the H. pylori isolates and used for amplification of vacA alleles and the cagA gene. Statistical analysis was performed to determine the association between H. pylori genotypes, age (< 40 years vs > 40 years) and sex of the patient, and gastric diseases.

resultsCG was the most prevalent gastric disease (113/233; 48.5%), compared to GU (64/233; 27.5%) and DU (56/233; 24%). More patients were male, and gastric diseases were more frequent in patients > 40 years (P < 0.05). The percentage of CG and GU patients that were male and female did not show a significant difference; however DU was more common in males (P < 0.05). Interestingly, a diagnosis of CG in patients > 40 years was more common in females (18.5%) than males (11.6%) (P = 0.05), whereas a diagnosis of GU or DU in patients > 40 years was more frequent in males (14.6% vs 10.7% and 12.4% vs 4.3%, respectively). Overall, genotyping of the H. pylori isolates revealed that the vacA s1 (82%), vacA m2 (70%), and cagA (+) (72.5%) alleles were more frequent than vacA s2 (18%), vacA m1 (29.2%), and cagA(-) (all P < 0.05). The vacA s1m2cagA (+) genotype was the most prevalent within the three disease groups. vacA s1m2 frequency was 56.2% with a similar occurrence in all diagnoses, while vacA s1m1 appeared more often in DU patients (33.9%). A genotype of vacA s2m2 occurred in 15% of isolates and was more common in CG patients (21.2%); vacA s2m1 was the least common genotype (3%). The vacA s1 allele was found to be a risk factor for DU, vacA s2 for CG, and vacA s1 and vacA s2 for GU (all P < 0.05). The vacA s2m2 genotype was associated with the development of CG and GU compared to DU (P < 0.05). No correlation was found between vacA m or cagA and gastric diseases.

conclusionThe outcome of H. pylori infection is the result of interaction between bacterial genotypes and the age and sex of infected individuals.

Indexed as

AdultAge FactorsAntigens, BacterialBacterial ProteinsBiopsyChronic DiseaseDNA, BacterialDuodenal UlcerFemaleGastritisGenotypeHelicobacter InfectionsHelicobacter pyloriHost-Pathogen InteractionsHumansIranAntigens, BacterialBacterial ProteinscagA protein, Helicobacter pyloriDNA, BacterialVacA protein, Helicobacter pyloriAgeGastric diseaseGenderGenotypeHelicobacter pylori

Identifiers

PMID26309357
PMCPMC4541383
OpenAlexW1126406605

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.